Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrp Advisory Group Regulatory News (FRP)

Share Price Information for Frp Advisory Group (FRP)

Share Price is delayed by 15 minutes
Get Live Data
112.50    -1.00 (-0.88%)
Bid:
112.00
Ask:
113.00
Spread: 1.00 (0.893%)
Market Cap: £279.21m
FRP Live PriceLast checked at - London Stock Exchange

Intraday Frp Advisory Group Share Chart

Directors' Dealings

12 Jan 2010 17:21

RNS Number : 4478F
Fairpoint Group PLC
12 January 2010
 

Directors' Dealings

 

The Company announces that under the Fairpoint Group plc Joint Ownership Plan ("the Plan") the Company approved the award of a joint beneficial ownership to key senior management over ordinary shares of 1p in the Company (the "Shares") on 11 January 2010. The Shares will be held jointly with Lloyds TSB, as trustee of the Fairpoint Group plc Employee Trust ("Trustee"). Subject to performance conditions and continued employment within the Group, the awards have an effective strike price of 84p per share and are subject to a performance period to 31 December 2012.

 

Under the Plan Chris Moat, Chief Executive Officer was awarded a joint beneficial interest in 385,000 Shares; Andrew Heath, Finance Director was awarded a joint beneficial interest in 110,000 Shares and Derek Oakley, Insolvency Director was awarded a joint beneficial interest in 41,250 Shares. The number of Shares that will vest will be determined based on the extent to which defined performance conditions have been achieved. For Mr Heath and Mr Oakley 50% of the Shares will vest if the Company's share price in the three years to 31 December 2012 over a thirty day period averages 122p or greater and 100% if in the three years to 31 December 2012 the Company's share price averages 183p or greater. For Mr Moat 100% of the shares will vest if in the three years to 31 December 2012 the Company's share price averages 183p or greater.

A payment of 1p per Share was paid by the participants for their respective interest in the Shares. 

Should the performance conditions not be achieved then the participants will be obliged to sell their respective interests in the Shares to the trustee at the lower of market value and 1p per Share.

Following the determination of the performance conditions, the value of the award is to be determined based on the excess of the share price above 84p. 

The beneficial interest in the Shares is jointly owned by the participants and the Trustees as co-owners. The participants will hold no voting rights over the Ordinary Shares prior to the satisfaction of the Performance ConditionsFollowing such satisfactionthe participants may instruct the Trustee to vote in accordance with their wishes othe number of Shares proportionate to their respective interests.

Following the awardthe directors will have the following interests in the ordinary share capital of the Company:

Director

Number of options held over ordinary shares

Number of ordinary shares co-owned with the trustee

Mr Moat

900,000

385,000

Mr Heath

150,000

110,000

Mr Oakley

412,500

41,250

Enquiries:

Fairpoint Group plc  Chris Moat, Chief Executive Officer  0845 296 0100

Andy Heath, Finance Director  0845 296 0200

Shore Capital (Nomad and Joint Broker) 

Guy Peters 020 7408 4090

Oriel Securities (Joint Broker)

Tom Durie 020 7710 7600

Emma Griffin

Financial Dynamics Nick Henderson  020 7269 7114

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGURGGUPUGMP
Date   Source Headline
21st May 20264:39 pmRNSHolding(s) in Company
21st May 20264:22 pmRNSPurchase of Ordinary Shares by EBT
15th May 20267:00 amRNSFull Year Trading Update
27th Apr 20267:00 amRNSShareholder Lock-Ins
20th Mar 202610:43 amRNSHolding(s) in Company
17th Mar 20261:49 pmRNSHolding(s) in Company
27th Feb 20266:15 pmRNSHolding(s) in Company
27th Feb 20266:08 pmRNSHolding(s) in Company
23rd Feb 20267:00 amRNSQ3 Dividend Declaration
13th Jan 20262:51 pmRNSChange of Auditor
9th Jan 20263:40 pmRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
19th Dec 20257:00 amRNSGrant of Options and Director Dealing
18th Dec 20257:00 amRNSHalf-year Report
1st Dec 20256:08 pmRNSTotal Voting Rights
21st Nov 20257:00 amRNSTrading Statement
14th Nov 20257:00 amRNSAcquisition of Arc & Co Structured Finance Limited
23rd Sep 20253:43 pmRNSResult of AGM
23rd Sep 20257:00 amRNSAGM Statement and Q1 Dividend Declaration
3rd Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20255:32 pmRNSNotice of Annual General Meeting
19th Aug 202510:04 amRNSAnnual Financial Report
19th Aug 20258:45 amRNSGrant of Options and Director Dealing
23rd Jul 20257:00 amRNSFull Year Results
30th May 20257:00 amRNSTotal Voting Rights
12th May 20257:00 amRNSAcquisition of One Advisory Group
8th May 20257:00 amRNSFull Year Trading Update
1st May 20253:35 pmRNSAIM Rule 17 Update
11th Mar 20251:55 pmRNSDirector/PDMR Shareholding
17th Feb 20257:00 amRNSQ3 Trading Update and Dividend Declaration
14th Jan 20257:00 amRNSAppointment of Joint Corporate Broker
10th Jan 20255:00 pmRNSDirector/PDMR Shareholding
17th Dec 20247:00 amRNSHalf-year Report
20th Nov 20247:00 amRNSHalf Year Trading Update
31st Oct 20247:00 amRNSTotal Voting Rights
25th Oct 20247:00 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSAcquisition of Globalview Advisors Limited
15th Oct 20242:42 pmRNSPDMR Dealing
30th Sep 202410:22 amRNSTotal Voting Rights
26th Sep 202410:49 amRNSResult of AGM
26th Sep 20247:00 amRNSAGM Statement and Q1 Dividend Declaration
23rd Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSAcquisition of WilliamsAli Corporate Finance
23rd Aug 20247:00 amRNSNotice of AGM
16th Aug 202411:39 amRNSAnnual Report & Accounts
1st Aug 20243:35 pmRNSDirector/PDMR Shareholding
31st Jul 202410:50 amRNSTotal Voting Rights
24th Jul 20242:40 pmRNSReplacement - Full Year Results
24th Jul 20247:00 amRNSFull Year Results
19th Jul 202411:43 amRNSAcquisition of Lexington Corporate Finance

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.